WGS of off-target analysis of base editing in organoids
Seven clonal organoid lines and one bulk wild-type control sample were paired-end whole-genome sequenced using the Illumina Novaseq 6000 system. We sequenced four clonal intestinal organoid lines harbouring engineered TP53 and FBXW7 mutations as well as three lines targeted for oncogenic APC/TP53/PIK3CA/SMAD4 mutations. The reads were mapped to hg38 genome assembly and data is provided as BAM files.
- 8 samples
- DAC: EGAC00001001864
- Technology: Illumina NovaSeq 6000
The Princess Maxima Center for pediatric oncology default access policy to enable re-production of research and re-use of data for scientific purposes.
Please contact the DAC for the most up to date policies.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001006886 | Other |